Amphastar Pharmaceuticals, Inc.
AMPH· Nasdaq
AMPHAmphastar Pharmaceuticals, Inc.
Filed Mar 15, 2016 · 10-K · 75 days after period end · 0001558370-16-004146
| Metric | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|
| Revenue | $76.91M | $55.88M | $54.88M |
| Net Income | $7.53M | -$2.52M | $1.83M |
| EPS Diluted | $0.16 | -$0.06 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amphastar Pharmaceuticals, Inc. · CIK 1297184 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 15, 2016 · 75 d after period end
